Chester County News and Community Website
Verrica Pharmaceuticals Inc. (Nasdaq: VRCA), headquartered in West Chester, PA, is a dermatology therapeutics company developing medications for skin diseases requiring medical interventions. For more information, visit www.verrica.com.
WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA) announced a significant surge in demand for its lead product, YCANTH®, in the second quarter of 2025, reporting 13,434 dispensed applicator …
Verrica Reports Strong Q2 Growth as YCANTH Demand Accelerates Read More WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA) has announced an amended collaboration and licensing agreement with Torii Pharmaceutical Co. Ltd. to initiate a global Phase 3 clinical trial …
Verrica Pharmaceuticals Advances Global Phase 3 Trial for YCANTH with Amended Torii Agreement Read More WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA) has announced that its President and Chief Executive Officer, Jayson Rieger, PhD, MBA, will speak at the prestigious Jefferies Global Healthcare …
Verrica Pharmaceuticals to Present at Jefferies Global Healthcare Conference Read More WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA) has announced significant progress in the first quarter of 2025, reporting $3.4 million in revenue from YCANTH. This figure reflects a …
Verrica Pharmaceuticals Reports Record Q1 Revenue and Advancements in Pipeline Read More WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA) announced that Jayson Rieger, PhD, MBA, President and Chief Executive Officer, will represent the company at the Citizens Life Sciences Conference …
Verrica Pharmaceuticals CEO to Present at Citizens Life Sciences Conference Read More WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA) has announced robust demand-led growth for its molluscum contagiosum treatment, YCANTH®, during the first quarter of 2025. The company reported a …
Verrica Pharmaceuticals Reports Strong First-Quarter Growth for YCANTH Read More WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA) has announced the appointment of Dr. Gavin Corcoran to its Board of Directors.
Verrica Pharmaceuticals Adds Dr. Gavin Corcoran to Board of Directors Read More WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA), a dermatology-focused therapeutics company, has announced its participation in the 24th Annual Needham Virtual Healthcare Conference. Jayson Rieger, PhD, MBA, President and …
Verrica Pharmaceuticals to Present at Needham Healthcare Conference Read More WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA) has announced the appointment of Dr. Noah L. Rosenberg as Chief Medical Officer, a strategic move aimed at strengthening the company’s efforts …
Verrica Pharmaceuticals Appoints Dr. Noah Rosenberg as Chief Medical Officer Read More WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA) has reported its financial results for the fourth quarter and full year ending December 31, 2024, marking significant progress in its turnaround …
Verrica Pharmaceuticals Reports Q4 2024 Growth and Pipeline Progress Read More